Explore how GLP-1 and GIP therapies are revolutionizing type 2 diabetes treatment through innovative gut-hormone approaches.
Discover how SGLT3A and GLP-1 follow 24-hour rhythms in the mouse small bowel, regulating metabolism through circadian biology.
Discover how Exendin-4, derived from Gila monster venom, shows promise in treating diabetic retinopathy through neuroprotective mechanisms.
Discover how the brain acts as the master regulator of blood glucose through GLP-1 hormone signaling and cerebral glucose detection mechanisms.